Effectiveness and cost-effectiveness of combination therapy versus monotherapy in malignant melanoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Effectiveness and cost-effectiveness of combination therapy versus monotherapy in malignant melanoma ; volume:16 ; number:1 ; day:25 ; month:9 ; year:2023 ; pages:1-15 ; date:12.2023
Journal of pharmaceutical policy and practice ; 16, Heft 1 (25.9.2023), 1-15, 12.2023
- Urheber
-
Özdemir, Dilay
Büssgen, Melanie
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40545-023-00611-7
- URN
-
urn:nbn:de:101:1-2024020113511132790796
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
2025-08-15T07:24:36+0200
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Özdemir, Dilay
- Büssgen, Melanie
- SpringerLink (Online service)
Ähnliche Objekte (12)
The cost-effectiveness of nivolumab monotherapy for the treatment of advanced melanoma patients in England
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
The probability of cost-effectiveness
Cost-effectiveness analysis for clinicians
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study
Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve
Meniscal allograft transplantation after meniscectomy: clinical effectiveness and cost-effectiveness
Cost-Effectiveness of Targeted Reemployment Bonuses
Challenges in synthesising cost-effectiveness estimates
Cost-effectiveness and algorithmic decision-making
Cost-effectiveness of TAS-102 plus bevacizumab versus TAS-102 monotherapy in patients with metastatic colorectal cancer
Online Cost-Effectiveness ANalysis (OCEAN): a user-friendly interface to conduct cost-effectiveness analyses for cervical cancer
The cost-effectiveness of nivolumab monotherapy for the treatment of advanced melanoma patients in England
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
The probability of cost-effectiveness
Cost-effectiveness analysis for clinicians
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study
Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve
Meniscal allograft transplantation after meniscectomy: clinical effectiveness and cost-effectiveness
Cost-Effectiveness of Targeted Reemployment Bonuses
Challenges in synthesising cost-effectiveness estimates
Cost-effectiveness and algorithmic decision-making
Cost-effectiveness of TAS-102 plus bevacizumab versus TAS-102 monotherapy in patients with metastatic colorectal cancer
Online Cost-Effectiveness ANalysis (OCEAN): a user-friendly interface to conduct cost-effectiveness analyses for cervical cancer
The cost-effectiveness of nivolumab monotherapy for the treatment of advanced melanoma patients in England
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
The probability of cost-effectiveness
Cost-effectiveness analysis for clinicians
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study
Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve
Meniscal allograft transplantation after meniscectomy: clinical effectiveness and cost-effectiveness
Cost-Effectiveness of Targeted Reemployment Bonuses
Challenges in synthesising cost-effectiveness estimates
Cost-effectiveness and algorithmic decision-making
Cost-effectiveness of TAS-102 plus bevacizumab versus TAS-102 monotherapy in patients with metastatic colorectal cancer